Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sayaka Tahara"'
Autor:
Kazunori Imada, Yoshitaka Miyakawa, Satoshi Ichikawa, Hitoji Uchiyama, Yasunori Ueda, Yasuhiro Hashimoto, Masashi Nishimi, Masako Tsukamoto, Sayaka Tahara, Masanori Matsumoto
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background A recent Phase 2/3 study in Japanese patients showed that caplacizumab was effective in treating immune-mediated thrombotic thrombocytopenic purpura (iTTP), with a low rate of iTTP recurrence. ADAMTS13 activity is monitored weekly
Externí odkaz:
https://doaj.org/article/871d701cd0654ce9b4f10eafb205124e
Autor:
Yuki Hamada, Mei Ikeda, Shinju Shimotakahara, Sayaka Tahara, Nao Onobuchi, Yoshiki Kanda, Go Takaguchi, Hideki Matsuoka
Publikováno v:
Journal of Neuroendovascular Therapy. 16:503-509
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9193df22b425d782981f9724533176ab
https://doi.org/10.5797/jnet.cr.2022-0023
https://doi.org/10.5797/jnet.cr.2022-0023
Autor:
Yoshitaka Miyakawa, Kazunori Imada, Satoshi Ichikawa, Hitoji Uchiyama, Yasunori Ueda, Akihito Yonezawa, Shigeki Fujitani, Yoshiyuki Ogawa, Tadashi Matsushita, Hidesaku Asakura, Kenji Nishio, Kodai Suzuki, Yasuhiro Hashimoto, Hidenori Murakami, Sayaka Tahara, Tomoyuki Tanaka, Masanori Matsumoto
Publikováno v:
International journal of hematology.
Caplacizumab is an anti-von Willebrand factor humanized single-variable-domain immunoglobulin fragment whose efficacy and safety in immune-mediated thrombotic thrombocytopenia purpura (iTTP) have been demonstrated in international studies. This prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53703035f6f2795def11c2eb795c78c0
https://pubmed.ncbi.nlm.nih.gov/36427162
https://pubmed.ncbi.nlm.nih.gov/36427162
Autor:
Kenji Nishio, Masanori Matsumoto, Yoshitaka Miyakawa, Hitoji Uchiyama, Satoshi Ichikawa, Shinobu Ohshima, Yasuhiro Hashimoto, Kodai Suzuki, Yasunori Ueda, Kazunori Imada, Hidesaku Asakura, Hiroshi Handa, Tomoyuki Tanaka, Shigeki Fujitani, Tadashi Matsushita, Akihito Yonezawa, Sayaka Tahara
Publikováno v:
Blood. 138:1009-1009
Introduction Immune-mediated thrombotic thrombocytopenic purpura (iTTP), or acquired TTP (aTTP), is a life-threatening thrombotic microangiopathy that requires prompt treatment to improve patient outcomes. Caplacizumab is a von Willebrand factor (VWF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a940c691f8eb7fc9a47768334f04ec8d
https://doi.org/10.1182/blood-2021-148427
https://doi.org/10.1182/blood-2021-148427
Autor:
Kentaro Morita, Yoichi Maekawa, Yoshio Osada, Isao Nagano, Katsuko Sudo, Tamotsu Kanazawa, Tsubasa Ishihara, Susumu Nakae, Zhiliang Wu, Sayaka Tahara
Publikováno v:
Parasite Immunology. 42
Aims Many parasitic helminths are known to alter host immune responses and consequently affect the progression of autoimmune and allergic diseases. The parasitic nematode Trichinella sp has been reported to suppress several experimental diseases in r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd180a846dd42bf3a953e81833b29f3
https://doi.org/10.1111/pim.12677
https://doi.org/10.1111/pim.12677
Publikováno v:
Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 146(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13971d6d20c1ffbb0c4c7d5911d8225
https://pubmed.ncbi.nlm.nih.gov/26165343
https://pubmed.ncbi.nlm.nih.gov/26165343
Publikováno v:
Molecular Biology of the Cell. 9:1577-1588
In the fission yeast Schizosaccharomyces pombe, passage from G1to S-phase requires the execution of the transcriptional factor complex that consists of the Cdc10 and Res1/2 molecules. This complex activates the MluI cell cycle box cis-element contain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3239dd556e85b1bb272e67cba5c10d0
https://doi.org/10.1091/mbc.9.6.1577
https://doi.org/10.1091/mbc.9.6.1577